Murray Hill – Managing Director & CEO – Elevate Uranium (ASX:EL8) is a uranium exploration company that has significant resources in Namibia and Australia and is making new discoveries through active exploration programs.
Copyright 2024 – Finance News Network
Source: Finance News Network
05 Aug 2024 - BlinkLab Limited (ASX:BB1) Non-Executive Chairman Brian Leedman discusses transforming smartphones into diagnostic tools.
Read More29 Aug 2024 - Corella Resources Limited (ASX:CR9) CEO Jess Maddren provides an overview of the business, discussing novel steps for high-purity alumina flowsheeting.
Read More17 Aug 2022 - CARETEQ Limited (ASX:CTQ) Executive Chairman Mark Simari discusses the company's recent agreement with drug management platform StrongRoom AI and the transition from paper-based to digital record keeping within the aged care and assistive living sector.
Read More05 Feb 2021 - Centuria Office REIT (ASX:COF) Fund Manager Grant Nichols discusses 1H21 highlights, the market conditions for leasing, and the outlook and trends for office markets.
Read More16 Oct 2023 - In this interview, the Managing Director of Cooper Metals (ASX:CPM) discusses their active drilling program at the Mount Isa region, focusing on copper and gold prospects.
Read More29 Jul 2022 - INOVIQ Limited (ASX:IIQ) CEO Dr Leearne Hinch discusses recent key announcements, including the appointment of a US sales team, the securing of a US patent, quarterly results, and the year ahead.
Read More13 May 2025 - Mission-critical communications with global expansion potential.
Read More23 Apr 2025 - The road to commercialisation: Overcoming funding and regulatory hurdles in battery storage
Read More17 Aug 2022 - WT Financial Group Limited (ASX:WTL) Founder and Managing Director Keith Cullen discusses the company's indicative results and the future of financial advice.
Read More11 Dec 2020 - Cyclopharm Limited (ASX:CYC) CEO & Managing Director James McBrayer talks about USFDA approval for Technegas, the company's USA commercialisation plan, and opportunities beyond its key diagnostic market for pulmonary embolism.
Read More
